NIH to Test Experimental Drug to Curb Opioid Cravings

A clinical trial of an experimental drug designed to treat cravings associated with OUD has begun in the National Institutes of Health Clinical Center. The Phase I trial in healthy adults will assess the safety of the experimental compound, ANS-6637, and how it is processed in the body when given with another drug that is processed by the same liver enzyme pathway. 

Continue reading
Topics:

Medications to Treat Opioid Addiction Are Effective and Save Lives, But Barriers Prevent Broad Access and Use, Says New Report

A new report from the National Academies of Sciences, Engineering and Medicine, Medications for Opioid Use Disorder Save Lives , says that withholding or failing to have available medications for the treatment of OUD in ...
Continue reading
Topics:

Become part of this distinguished, multimodal, interdisciplinary community.

Join AAPM